openPR Logo
Press release

DNA Fluhunter - First commercial DNA-Test worldwide to detects all pathogenic strains of bird flu H5, N1, H9 and H7

12-23-2005 04:26 PM CET | Health & Medicine

Press release from: Genekam Biotechnology AG

/ PR Agency: Genekam Biotechnology AG
Duisburg 22. Dezember 2005 Genekam Biotechnology AG has now developed the first commercial DNA-Test of the world to detect all dangerous types of bird flu H5, N1, H7, H9. These stocks lead to disease and death in both human and animals. Especially H5 and H7 are aggressive to birds, leading to mortality and economical losses in a short time.



DNA-tests have the particular feature to be most reliable, accurate and fast in performance. Since 1999 DNA tests have been used to screen all transfusion blood samples in Germany for HIV, HBV and HCV, as there were reports of infections amongst human getting the transfusion blood tested through serological tests.



The same problem occurs the nowadays, as serological (so called rapid) tests are being performed to detect bird flu viruses in many countries China, Vietnam, Indonesia, Cambodia etc). But serological tests have the major problem to be imprecise and are leading to cross reactions. Many times false alarm haven been made. Although history tells that the problems of serological tests, but still many Governments are using these tests to fight a very clever enemy.



By using the Genekam DNA-FluHunter such tests under field conditions can be performed in shortest time – prevention methods may be induced just in time. No serological tests worldwide is able to differ between those dangerous viruses H5N1, H7 and H9 at the same time – Genekam DNA-FluHunter can do this, therefore it is the perfect match for monitoring this virus. One should not forget that monitoring is the first step to prevent the spread of infection. Years ago, the spreading of SARS has successfully been managed using DNA-test methods and other public health methods and there is a little need to stockpile the antiviral drugs as done with bird flu. At present, the Governments are stockpiled with the antiviral drugs, but affective prevention methods i.e. monitoring proved to be more meaningful than stockpiling the antiviral drugs in the case of SARS. Therefore there should be more stress on the monitoring of the virus.



Genekam DNA-FluHunter can be performed for both human and animals. Especially symptomless carriers such as waterfowl (so called carriers) may be tested for H5N1, H7 and H9 at the same time through DNA-Fluhunter.



Mr. Michael Ulle PR Director added “Where the people do not have the access to lastest technology of DNA tests. It is very simple to get the test done just sending 0.5 ml Blood in EDTA to our laboratory though post or currier from any part of the world. This offer may be of interest for the staff of embassies, international companies and travellers. The price is Euro 69,– (in case of a positive result Euro 149,– for gene sequencing). Even fast food-stores, food manufacturer and discounter can now test its product range. This service delivery is available immediately. Genekam DNA-FluHunter is also available as kit for other laboratories as they can take samples on-site and check them.”



The company Genekam Biotechnology AG has developed and distributed about 120 DNA tests so far on the world market. Furthermore, Genekam performs the DNA tests for various viruses, bacteria and parasites for both human and animals.





GENEKAM Biotechnology AG
Dammstraße 31-33
47119 Duisburg
Tel. +49-203-55 58 58-31
Fax +49-203-35 82 99

eMail: query@genekam.de Website: www.genekam.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DNA Fluhunter - First commercial DNA-Test worldwide to detects all pathogenic strains of bird flu H5, N1, H9 and H7 here

News-ID: 1881 • Views:

More Releases from Genekam Biotechnology AG

World Innovation: First therapeutic molecule candidate against Zika viruses
World Innovation: First therapeutic molecule candidate against Zika viruses
Genekam Biotechnology AG, which developed the first test for Zikavrius detection in Januar 2016, has developed as one of first company in the world the therapeutic molecule candidate for Zika viruses, which is likely to be the first potential candidate for Zika-virus therapy. Zika viruses are known to cause fears as they infect pregnant women leading to disorders and new born with microencephaly (child with smaller head) with whole life handicap
DNA-FluHunter - The all-rounder weapon against bird flu virus
First commercial DNA-Test worldwide to detect all pathogenic strains of bird flu H5, N1, H9 and H7. Duisburg, July 31 2007: Genekam Biotechnology AG has now developed the first commercial DNA-Test of the world to detect all dangerous types of bird flu H5, N1, H7, H9. These stocks lead to disease and death in both human and animals. Especially H5 and H7 are aggressive to birds, leading to mortality and economical
First worldwide commercial DNA Test for H5N1 and H9 to detect avian influenza vi …
Genekam Bird flu DNA-Test (H5N1, H9) Duisburg, December 7th, 2005 With help of modern technology, German’s molecular medicine company Genekam did a good job on developing a most reliable and accurate DNA-based test that is able to detect the avian influenza virus H5N1 along with the not less dangerous H9 virus in a very short time. This DNA test is not only reliable and most accurate. It can be performed under

All 4 Releases


More Releases for DNA

High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production. Key factors driving the market include: Increasing adoption of gene and cell therapies Rising prevalence of chronic and rare genetic disorders Expansion of DNA-based
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true. https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global DNA Paternity Testing Market: This report studies the Global DNA Paternity Testing